Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cuenca-Barrales

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Dermatology and Therapy|February 14, 2023
Potential Predictors of Cardiovascular Risk Improvement in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A Pivotal Study of Factors Associated with Carotid Intima-Media Thickness ReductionManuel Sánchez-Díaz, Luis Salvador-Rodríguez, Carlos Cuenca-Barrales, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 16, 2022
Prevalence and implications of type D personality in patients with alopecia areata: A marker of quality-of-life impairment and mood status disturbances, a comparative studyManuel Sánchez-Díaz, Trinidad Montero-Vílchez, Carlos Cuenca-Barrales, et al.
Sultan Qaboos University Medical Journal|September 14, 2018
Inflammatory Reactions to Red Tattoo Inks: Three cases highlighting an emerging problemRicardo Ruiz-Villaverde, Pablo Fernandez-Crehuet, Paula Aguayo-Carreras, et al.
International Journal of Dermatology|October 15, 2024
Therapeutic burden in hidradenitis suppurativa: a cross-sectional study of 557 patientsSofía Haselgruber, Daniel Muñoz-Barba, Francisco Javier Leon-Pérez, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 15, 2021
Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care WorkersTrinidad Montero-Vilchez, Antonio Martinez-Lopez, Carlos Cuenca-Barrales, et al.
Journal of Clinical Medicine|February 25, 2022
Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis SuppurativaTrinidad Montero-Vilchez, Carlos Cuenca-Barrales, Andrea Rodriguez-Tejero, et al.
Life (Basel, Switzerland)|August 6, 2021
The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort StudyTrinidad Montero-Vilchez, Andrea Valenzuela-Amigo, Carlos Cuenca-Barrales, et al.
Dermatology (Basel, Switzerland)|January 21, 2021
Implications of Hidradenitis Suppurativa Phenotypes in Cardiovascular Risk and Treatment Decisions: A Retrospective Cohort StudyCarlos Cuenca-Barrales, Trinidad Montero-Vilchez, Luis Salvador-Rodríguez, et al.
The Australasian Journal of Dermatology|April 15, 2020
Nodular lichen myxoedematous: a new adverse event associated with ustekinumabTrinidad Montero-Vilchez, Antonio Martinez-Lopez, Carlos Cuenca-Barrales, et al.
Indian Journal of Dermatology|September 8, 2025
Impact of Hidradenitis Suppurativa on Major Life-Changing Decisions: A Cross-Sectional StudyClara Ureña-Paniego, Alberto Soto-Moreno, Pablo Díaz-Calvillo, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Dermatology and Therapy|February 14, 2023
Potential Predictors of Cardiovascular Risk Improvement in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A Pivotal Study of Factors Associated with Carotid Intima-Media Thickness ReductionManuel Sánchez-Díaz, Luis Salvador-Rodríguez, Carlos Cuenca-Barrales, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 16, 2022
Prevalence and implications of type D personality in patients with alopecia areata: A marker of quality-of-life impairment and mood status disturbances, a comparative studyManuel Sánchez-Díaz, Trinidad Montero-Vílchez, Carlos Cuenca-Barrales, et al.
Sultan Qaboos University Medical Journal|September 14, 2018
Inflammatory Reactions to Red Tattoo Inks: Three cases highlighting an emerging problemRicardo Ruiz-Villaverde, Pablo Fernandez-Crehuet, Paula Aguayo-Carreras, et al.
International Journal of Dermatology|October 15, 2024
Therapeutic burden in hidradenitis suppurativa: a cross-sectional study of 557 patientsSofía Haselgruber, Daniel Muñoz-Barba, Francisco Javier Leon-Pérez, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 15, 2021
Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care WorkersTrinidad Montero-Vilchez, Antonio Martinez-Lopez, Carlos Cuenca-Barrales, et al.
Journal of Clinical Medicine|February 25, 2022
Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis SuppurativaTrinidad Montero-Vilchez, Carlos Cuenca-Barrales, Andrea Rodriguez-Tejero, et al.
Life (Basel, Switzerland)|August 6, 2021
The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort StudyTrinidad Montero-Vilchez, Andrea Valenzuela-Amigo, Carlos Cuenca-Barrales, et al.
Dermatology (Basel, Switzerland)|January 21, 2021
Implications of Hidradenitis Suppurativa Phenotypes in Cardiovascular Risk and Treatment Decisions: A Retrospective Cohort StudyCarlos Cuenca-Barrales, Trinidad Montero-Vilchez, Luis Salvador-Rodríguez, et al.
The Australasian Journal of Dermatology|April 15, 2020
Nodular lichen myxoedematous: a new adverse event associated with ustekinumabTrinidad Montero-Vilchez, Antonio Martinez-Lopez, Carlos Cuenca-Barrales, et al.
Indian Journal of Dermatology|September 8, 2025
Impact of Hidradenitis Suppurativa on Major Life-Changing Decisions: A Cross-Sectional StudyClara Ureña-Paniego, Alberto Soto-Moreno, Pablo Díaz-Calvillo, et al.
Pageof 5